These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18173807)

  • 1. CORONA--rosuvastatin in older patients with systolic heart failure.
    Jackson G
    Int J Clin Pract; 2008 Jan; 62(1):1. PubMed ID: 18173807
    [No Abstract]   [Full Text] [Related]  

  • 2. [The CORONA study].
    Metra M; Zacá V; Nodari S; Cas LD; Maggioni AP
    G Ital Cardiol (Rome); 2008 Apr; 9(4):229-33. PubMed ID: 18543792
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Gadaleta A; Frisardi V; Santamato A; Capurso A; Panza F
    J Am Geriatr Soc; 2008 Jul; 56(7):1366-7. PubMed ID: 18774975
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).
    Serebruany VL
    Am J Cardiol; 2008 Jun; 101(12):1808-9. PubMed ID: 18549865
    [No Abstract]   [Full Text] [Related]  

  • 5. CORONA study highlights challenges of treating older patients with systolic heart failure.
    Cardiovasc J Afr; 2007; 18(6):402-4. PubMed ID: 18092121
    [No Abstract]   [Full Text] [Related]  

  • 6. CORONA, statins, and heart failure: who lost the crown?
    Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
    Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosuvastatin in older patients with systolic heart failure.
    Florkowski CM; Molyneux SL; George PM
    N Engl J Med; 2008 Mar; 358(12):1301; author reply 1301. PubMed ID: 18354111
    [No Abstract]   [Full Text] [Related]  

  • 8. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; Adourian A; Böhm M; van Veldhuisen DJ; Komajda M; Cleland JG; Wikstrand J; McMurray JJ; Aukrust P;
    Eur Heart J; 2012 Sep; 33(18):2290-6. PubMed ID: 22513778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin in patients with elevated C-reactive protein.
    Pierard LA
    N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosuvastatin and cardiovascular continuum when time is important.
    Barrios V; Escobar C
    J Am Coll Cardiol; 2010 Apr; 55(15):1645-6; author reply 1646. PubMed ID: 20378088
    [No Abstract]   [Full Text] [Related]  

  • 11. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
    Daniels LB; Barrett-Connor E
    J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
    [No Abstract]   [Full Text] [Related]  

  • 12. [The GISSI-HF trial].
    Tavazzi L; Nodari S
    G Ital Cardiol (Rome); 2009 Mar; 10(3):129-34. PubMed ID: 19385306
    [No Abstract]   [Full Text] [Related]  

  • 13. Tailored therapy for heart failure: the role of biomarkers.
    Wollert KC
    Eur Heart J; 2012 Sep; 33(18):2246-8. PubMed ID: 22611133
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
    Tavazzi L; Tognoni G; Franzosi MG; Latini R; Maggioni AP; Marchioli R; Nicolosi GL; Porcu M;
    Eur J Heart Fail; 2004 Aug; 6(5):635-41. PubMed ID: 15302013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Mar; 155(2):296-9. PubMed ID: 22200185
    [No Abstract]   [Full Text] [Related]  

  • 16. [No reason to start treatment with statins in patients with moderate to severe heart failure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):486-8. PubMed ID: 18389878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Jupiter trial--new territory for statins?
    Wheeler DC
    Nephrol Dial Transplant; 2009 Jul; 24(7):2036-7. PubMed ID: 19541666
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) the answer to the cholesterol paradox in heart failure?
    Velavan P; Loh PH; Clark A; Cleland JG
    Congest Heart Fail; 2008; 14(1):55. PubMed ID: 18256572
    [No Abstract]   [Full Text] [Related]  

  • 19. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Aukrust P
    Am Heart J; 2012 Dec; 164(6):878-83. PubMed ID: 23194488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).
    McMurray JJ; Dunselman P; Wedel H; Cleland JG; Lindberg M; Hjalmarson A; Kjekshus J; Waagstein F; Apetrei E; Barrios V; Böhm M; Kamenský G; Komajda M; Mareev V; Wikstrand J;
    J Am Coll Cardiol; 2010 Oct; 56(15):1196-204. PubMed ID: 20883926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.